{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:25:00Z","timestamp":1794489900740,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1011119"],"award-info":[{"award-number":["A1011119"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1021227"],"award-info":[{"award-number":["A1021227"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1031135"],"award-info":[{"award-number":["A1031135"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1041122"],"award-info":[{"award-number":["A1041122"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1051013"],"award-info":[{"award-number":["A1051013"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1061224"],"award-info":[{"award-number":["A1061224"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The benefits of mammographic screening have been shown to include a decrease in mortality due to breast cancer. Taiwan\u2019s Breast Cancer Screening Program is a national screening program that has offered biennial mammographic breast cancer screening for women aged 50\u201369\u00a0years since 2004 and for those aged 45\u201369\u00a0years since 2009, with the implementation of mobile units in 2010. The purpose of this study was to compare the performance results of the program with changes in the previous (2004\u20132009) and latter (2010\u20132020) periods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort of 3,665,078 women who underwent biennial breast cancer mammography screenings from 2004 to 2020 was conducted, and data were obtained from the Health Promotion Administration, Ministry of Health and Welfare of Taiwan. We compared the participation of screened women and survival rates from breast cancer in the earlier and latter periods across national breast cancer screening programs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 3,665,078 women who underwent 8,169,869 examinations in the study population, the screened population increased from 3.9% in 2004 to 40% in 2019. The mean cancer detection rate was 4.76 and 4.08 cancers per 1000 screening mammograms in the earlier (2004\u20132009) and latter (2010\u20132020) periods, respectively. The 10-year survival rate increased from 89.68% in the early period to 97.33% in the latter period. The mean recall rate was 9.90% (95% CI: 9.83\u20139.97%) in the early period and decreased to 8.15% (95%CI, 8.13\u20138.17%) in the latter period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The evolution of breast cancer screening in Taiwan has yielded favorable outcomes by increasing the screening population, increasing the 10-year survival rate, and reducing the recall rate through the participation of young women, the implementation of a mobile unit service and quality assurance program, thereby providing historical evidence to policy makers to plan future needs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-03217-7","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:02:33Z","timestamp":1702652553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004\u20132020"],"prefix":"10.1186","volume":"21","author":[{"given":"Melissa Min-Szu","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Pham Thao","family":"Vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Hsiu-Hsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsian-He","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giu-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Li","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-6336","authenticated-orcid":false,"given":"Wing P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Ming-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"3","key":"3217_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3217_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp0708307","volume":"358","author":"P Porter","year":"2008","unstructured":"Porter P. \u201cWesternizing\u201d women\u2019s risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358(3):213\u20136. https:\/\/doi.org\/10.1056\/NEJMp0708307.","journal-title":"N Engl J Med"},{"issue":"1","key":"3217_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/bjc.2014.532","volume":"112","author":"IO Wong","year":"2015","unstructured":"Wong IO, Schooling CM, Cowling BJ, Leung GM. Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends. Br J Cancer. 2015;112(1):167\u201370. https:\/\/doi.org\/10.1038\/bjc.2014.532.","journal-title":"Br J Cancer"},{"issue":"1","key":"3217_CR4","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1038\/s41598-022-16056-y","volume":"12","author":"YC Chen","year":"2022","unstructured":"Chen YC, Su SY, Jhuang JR, et al. Forecast of a future leveling of the incidence trends of female breast cancer in Taiwan: an age-period-cohort analysis. Sci Rep. 2022;12(1):12481.","journal-title":"Sci Rep"},{"key":"3217_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jncimono\/1997.22.27","volume":"22","author":"S Shapiro","year":"1997","unstructured":"Shapiro S. Periodic screening for breast cancer: the HIP randomized controlled trial. Health insurance plan. J Natl Cancer Inst Monogr. 1997;22:27\u201330. https:\/\/doi.org\/10.1093\/jncimono\/1997.22.27.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"3217_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2214\/AJR.19.22205","volume":"214","author":"CS Lee","year":"2020","unstructured":"Lee CS, Monticciolo DL, Moy L. Screening guidelines update for average-risk and high-risk women. AJR Am J Roentgenol. 2020;214(2):316\u201323. https:\/\/doi.org\/10.2214\/AJR.19.22205.","journal-title":"AJR Am J Roentgenol"},{"key":"3217_CR7","unstructured":"Cancer today: data visualization tools for exploring the global cancer burden in 2020. International Agency for Research on Cancer. https:\/\/gco.iarc.fr\/today\/online-analysis-map. Accessed 20 Jan 2023."},{"key":"3217_CR8","unstructured":"Taiwan breast cancer, oral cancer, and colorectal cancer screening programs. https:\/\/www.hpa.gov.tw\/EngPages\/Detail.aspx?nodeid=1051&pid=5957. Accessed 20 Jan 2023."},{"issue":"3","key":"3217_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/028418699431357","volume":"38","author":"M Tubiana","year":"1999","unstructured":"Tubiana M, Koscielny S. The rationale for early diagnosis of cancer\u2013the example of breast cancer. Acta Oncol. 1999;38(3):295\u2013303. https:\/\/doi.org\/10.1080\/028418699431357.","journal-title":"Acta Oncol"},{"key":"3217_CR10","unstructured":"ACR BI-RADS\u00ae Atlas 5th Edition. https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/Bi-Rads. Accessed 20 Jan 2023."},{"issue":"1","key":"3217_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/ajr.165.1.7785586","volume":"165","author":"MN Linver","year":"1995","unstructured":"Linver MN, Osuch JR, Brenner RJ, Smith RA. The mammography audit: a primer for the mammography quality standards act (MQSA). AJR Am J Roentgenol. 1995;165(1):19\u201325.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3217_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016161174","volume":"283","author":"CD Lehman","year":"2017","unstructured":"Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DSM, Kerlikowske K, Henderson LM, Onega T, Tosteson ANA, Rauscher GH, et al. National performance benchmarks for modern screening digital mammography: update from the breast cancer surveillance consortium. Radiology. 2017;283(1):49\u201358. https:\/\/doi.org\/10.1148\/radiol.2016161174.","journal-title":"Radiology"},{"issue":"2","key":"3217_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12282-021-01315-z","volume":"29","author":"SY Su","year":"2022","unstructured":"Su SY. Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis. Breast Cancer. 2022;29(2):336\u201342. https:\/\/doi.org\/10.1007\/s12282-021-01315-z.","journal-title":"Breast Cancer"},{"issue":"12","key":"3217_CR14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jfma.2019.08.023","volume":"119","author":"CN Kuo","year":"2020","unstructured":"Kuo CN, Liao YM, Kuo LN, Tsai HJ, Chang WC, Yen Y. Cancers in Taiwan: practical insight from epidemiology, treatments, biomarkers, and cost. J Formos Med Assoc. 2020;119(12):1731\u201341. https:\/\/doi.org\/10.1016\/j.jfma.2019.08.023.","journal-title":"J Formos Med Assoc"},{"key":"3217_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"HK Patel","year":"2018","unstructured":"Patel HK, Bihani T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther. 2018;186:1\u201324. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.12.012.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3217_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41523-022-00411-3","volume":"8","author":"N Tung","year":"2022","unstructured":"Tung N, Garber JE. PARP inhibition in breast cancer: progress made and future hopes. NPJ Breast Cancer. 2022;8(1):47. https:\/\/doi.org\/10.1038\/s41523-022-00411-3.","journal-title":"NPJ Breast Cancer"},{"issue":"16","key":"3217_CR17","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3390\/cells11162508","volume":"11","author":"K Zhu","year":"2022","unstructured":"Zhu K, Wu Y, He P, et al. PI3K\/AKT\/mTOR-targeted therapy for breast cancer. Cells. 2022;11(16):2508. https:\/\/doi.org\/10.3390\/cells11162508. Published 2022 Aug 12.","journal-title":"Cells"},{"issue":"11","key":"3217_CR18","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-20-4726","volume":"27","author":"SM Tolaney","year":"2021","unstructured":"Tolaney SM, Kalinsky K, Kaklamani VG, et al. Eribulin plus pembrolizumab in patients with metastatic triple-negative breast cancer (ENHANCE 1): a phase Ib\/II study. Clin Cancer Res. 2021;27(11):3061\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4726.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3217_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","volume":"5","author":"LA Emens","year":"2019","unstructured":"Emens LA, Cruz C, Eder JP, et al. Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study. JAMA Oncol. 2019;5(1):74\u201382. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4224.","journal-title":"JAMA Oncol"},{"key":"3217_CR20","unstructured":"Survival Rates for Breast Cancer. https:\/\/www.cancer.org\/cancer\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html. Accessed 20 Jan 2023."},{"issue":"2","key":"3217_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijc.33204","volume":"148","author":"N Zielonke","year":"2021","unstructured":"Zielonke N, Kregting LM, Heijnsdijk EAM, et al. The potential of breast cancer screening in Europe. Int J Cancer. 2021;148(2):406\u201318. https:\/\/doi.org\/10.1002\/ijc.33204.","journal-title":"Int J Cancer"},{"key":"3217_CR22","unstructured":"Cancer Trends Progress Report. https:\/\/progressreport.cancer.gov\/detection\/breast_cancer. Accessed 28 Jan 2023."},{"key":"3217_CR23","unstructured":"USPSTF breast cancer screening draft recommendations. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/draft-recommendation\/breast-cancer-screening-adults#fullrecommendationstart. Accessed 28 Oct 2023."},{"issue":"4","key":"3217_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu AL. U.S. preventive services task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279\u201396. https:\/\/doi.org\/10.7326\/M15-2886.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3217_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2214\/AJR.17.19229","volume":"211","author":"CS Lee","year":"2018","unstructured":"Lee CS, Parise C, Burleson J, Seidenwurm D. Assessing the recall rate for screening mammography: comparing the medicare hospital compare dataset with the national mammography database. AJR Am J Roentgenol. 2018;211(1):127\u201332. https:\/\/doi.org\/10.2214\/AJR.17.19229.","journal-title":"AJR Am J Roentgenol"},{"issue":"55","key":"3217_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24550","volume":"24","author":"S Duffy","year":"2020","unstructured":"Duffy S, Vulkan D, Cuckle H, et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess. 2020;24(55):1\u201324. https:\/\/doi.org\/10.3310\/hta24550.","journal-title":"Health Technol Assess"},{"issue":"13","key":"3217_CR27","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.32859","volume":"126","author":"SW Duffy","year":"2020","unstructured":"Duffy SW, Tab\u00e1r L, Yen AM, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971\u20139. https:\/\/doi.org\/10.1002\/cncr.32859.","journal-title":"Cancer"},{"issue":"8433","key":"3217_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/s0140-6736(85)92204-4","volume":"1","author":"L Tab\u00e1r","year":"1985","unstructured":"Tab\u00e1r L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National board of health and welfare. Lancet. 1985;1(8433):829\u201332. https:\/\/doi.org\/10.1016\/s0140-6736(85)92204-4.","journal-title":"Lancet"},{"issue":"11","key":"3217_CR29","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.3310\/hta17110","volume":"17","author":"SW Duffy","year":"2013","unstructured":"Duffy SW, Mackay J, Thomas S, et al. Evaluation of mammographic surveillance services in women aged 40\u201349 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess. 2013;17(11):vii\u201395. https:\/\/doi.org\/10.3310\/hta17110.","journal-title":"Health Technol Assess"},{"issue":"9","key":"3217_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","volume":"16","author":"SM Moss","year":"2015","unstructured":"Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK age trial at 17 years\u2019 follow-up: a randomised controlled trial. Lancet Oncol. 2015;16(9):1123\u201332. https:\/\/doi.org\/10.1016\/S1470-2045(15)00128-X.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3217_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/radiology.201.2.8888236","volume":"201","author":"ND DeBruhl","year":"1996","unstructured":"DeBruhl ND, Bassett LW, Jessop NW, Mason AM. Mobile mammography: results of a national survey. Radiology. 1996;201(2):433\u20137. https:\/\/doi.org\/10.1148\/radiology.201.2.8888236.","journal-title":"Radiology"},{"issue":"1","key":"3217_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41523-022-00381-6","volume":"8","author":"AB van den Bruele","year":"2022","unstructured":"van den Bruele AB, Sevilimedu V, Jochelson M, Formenti S, Norton L, Sacchini V. Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program. NPJ Breast Cancer. 2022;8(1):14.","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"3217_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10552-017-0995-7","volume":"29","author":"ZR Greenwald","year":"2018","unstructured":"Greenwald ZR, Fregnani JH, Longatto-Filho A, et al. The performance of mobile screening units in a breast cancer screening program in Brazil. Cancer Causes Control. 2018;29(2):233\u201341. https:\/\/doi.org\/10.1007\/s10552-017-0995-7.","journal-title":"Cancer Causes Control"},{"key":"3217_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ypmed.2017.04.006","volume":"100","author":"E Guillaume","year":"2017","unstructured":"Guillaume E, Launay L, Dejardin O, et al. Could mobile mammography reduce social and geographic inequalities in breast cancer screening participation? Prev Med. 2017;100:84\u20138. https:\/\/doi.org\/10.1016\/j.ypmed.2017.04.006.","journal-title":"Prev Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03217-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:04:23Z","timestamp":1702652663000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03217-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved as exempt from the Taipei Medical University-Joint Institutional Review Board (N202112050), and written informed consent was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"497"}}